{"id":362476,"date":"2025-08-31T08:22:19","date_gmt":"2025-08-31T08:22:19","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-dr-reddys-laboratories-limited\/"},"modified":"2025-08-31T08:22:19","modified_gmt":"2025-08-31T08:22:19","slug":"how-to-buy-dr-reddys-laboratories-limited","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/","title":{"rendered":"Dr. Reddy&#8217;s Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Dr. Reddy&#8217;s Laboratories Limited (RDY) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334045,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-362476","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Dr. Reddy's Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dr. Reddy's Laboratories Limited (RDY) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Dr. Reddy's Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dr. Reddy's Laboratories Limited (RDY) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Fiyat trendleri, riskler ve 2025-2030 tahminlerini kapsayan kapsaml\u0131 yat\u0131r\u0131m analizimizle Dr. Reddy's Laboratories Limited (RDY) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Fiyat trendleri, riskler ve 2025-2030 tahminlerini kapsayan kapsaml\u0131 yat\u0131r\u0131m analizimizle Dr. Reddy's Laboratories Limited (RDY) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin."},"intro":"Hindistan'\u0131n ila\u00e7 devlerinden birine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Dr. Reddy's Laboratories Limited (RDY), geli\u015fmekte olan pazar b\u00fcy\u00fcmesi ile k\u00f6kl\u00fc ila\u00e7 sekt\u00f6r\u00fcn\u00fcn istikrar\u0131n\u0131 benzersiz bir \u015fekilde harmanl\u0131yor. D\u00fcnya genelinde 800 milyondan fazla hastaya hizmet vermesi ve 76 \u00fclkede g\u00fc\u00e7l\u00fc varl\u0131\u011f\u0131 ile bu \u015firket, yeni yat\u0131r\u0131mc\u0131lar i\u00e7in hem f\u0131rsat hem de zorluk anlam\u0131na geliyor. Bu yat\u0131r\u0131m karar\u0131n\u0131 verirken bilmeniz gereken her \u015feyi birlikte ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Hindistan'\u0131n ila\u00e7 devlerinden birine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Dr. Reddy's Laboratories Limited (RDY), geli\u015fmekte olan pazar b\u00fcy\u00fcmesi ile k\u00f6kl\u00fc ila\u00e7 sekt\u00f6r\u00fcn\u00fcn istikrar\u0131n\u0131 benzersiz bir \u015fekilde harmanl\u0131yor. D\u00fcnya genelinde 800 milyondan fazla hastaya hizmet vermesi ve 76 \u00fclkede g\u00fc\u00e7l\u00fc varl\u0131\u011f\u0131 ile bu \u015firket, yeni yat\u0131r\u0131mc\u0131lar i\u00e7in hem f\u0131rsat hem de zorluk anlam\u0131na geliyor. Bu yat\u0131r\u0131m karar\u0131n\u0131 verirken bilmeniz gereken her \u015feyi birlikte ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Mevcut Piyasa Konumu ve Giri\u015f Stratejisi<\/h2> <p>31 A\u011fustos 2025 itibar\u0131yla Dr. Reddy's Laboratories Limited (RDY), NYSE'de <strong>14,21 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Bu fiyat seviyesi, hisse senedini ilgin\u00e7 bir konuma yerle\u015ftiriyor - y\u0131ll\u0131k zirvelerinde de\u011fil ama kesinlikle \u00e7ok ucuz seviyelerde de de\u011fil.<\/p> <p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131<\/strong>: Takviminize <strong>4 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin. Dr. Reddy's bu tarihte 2. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak ve tarihsel olarak bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden oluyor. Son kazan\u00e7 raporu 25 Temmuz 2025'te a\u00e7\u0131kland\u0131 ve \u015firket beklentileri a\u015farak hisse ba\u015f\u0131na 0,22 $ ile 0,20 $ tahminlerini %10 oran\u0131nda ge\u00e7ti - bu genellikle hisseyi hareketlendiren sa\u011flam bir pozitif s\u00fcrprizdir.<\/p> <h3>Kazan\u00e7lar\u0131n Etki Analizi<\/h3> <p>Son kazan\u00e7 desenlerine bak\u0131ld\u0131\u011f\u0131nda, Dr. Reddy's tutarl\u0131 bir performans sergilemi\u015ftir:<\/p> <ul> <li><strong>Temmuz 2025<\/strong>: 0,22 $ EPS ile tahminleri %10 a\u015ft\u0131<\/li> <li><strong>\u00d6nceki \u00e7eyrek<\/strong>: Y\u0131ll\u0131k %11 g\u00fc\u00e7l\u00fc gelir art\u0131\u015f\u0131<\/li> <li><strong>Analist g\u00f6r\u00fc\u015f\u00fc<\/strong>: Bir\u00e7ok firma taraf\u0131ndan \"G\u00fc\u00e7l\u00fc Al\" olarak y\u00fckseltildi<\/li> <\/ul> <p>Bu desen, pozitif kazan\u00e7 s\u00fcrprizlerinin a\u00e7\u0131klamadan sonraki g\u00fcnlerde %3-5 aras\u0131nda anl\u0131k fiyat s\u0131\u00e7ramalar\u0131na yol a\u00e7t\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Seyri ve Trend Analizi<\/h2> <p>Dr. Reddy's hissesi son alt\u0131 ayda piyasa volatilitesi ve \u015firket \u00f6zel geli\u015fmelerini yans\u0131tan bir ini\u015f \u00e7\u0131k\u0131\u015f ya\u015fad\u0131:<\/p> <p><strong>Ocak-Mart 2025<\/strong>: Hisse 13,50-14,00 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc, k\u00fcresel piyasa belirsizli\u011fi i\u00e7inde istikrar g\u00f6sterdi<br\/> <strong>Nisan-Haziran 2025<\/strong>: \u00c7eyrek sonu\u00e7lar\u0131n\u0131n yat\u0131r\u0131mc\u0131lar\u0131 etkilemesiyle 14,50-15,00 $ seviyelerine kademeli y\u00fckseli\u015f<br\/> <strong>Temmuz-A\u011fustos 2025<\/strong>: Kar realizasyonu ve mevcut 14,21 $ seviyelerinde konsolidasyon<\/p> <p>Genel trend, <strong>\u0131l\u0131ml\u0131 de\u011fer art\u0131\u015f\u0131<\/strong> ve konsolidasyon d\u00f6nemleri g\u00f6steriyor. Hisse, piyasa d\u00fc\u015f\u00fc\u015flerinde dayan\u0131kl\u0131l\u0131k sergileyerek genellikle daha geni\u015f ila\u00e7 endekslerinin \u00fczerinde performans g\u00f6sterdi.<\/p> <p>Teknik g\u00f6stergeler \u015fu anda kar\u0131\u015f\u0131k sinyaller veriyor:<\/p> <ul> <li><strong>50 G\u00fcnl\u00fck SMA<\/strong>: 14,49 $ (mevcut fiyat biraz alt\u0131nda)<\/li> <li><strong>200 G\u00fcnl\u00fck SMA<\/strong>: 14,22 $ (mevcut fiyat bu seviyede)<\/li> <li><strong>RSI<\/strong>: 53,81 (n\u00f6tr b\u00f6lge)<\/li> <\/ul> <p>Bu teknik tablo, hissenin potansiyel bir d\u00f6n\u00fcm noktas\u0131nda oldu\u011funu ve zamanlaman\u0131n yeni yat\u0131r\u0131mc\u0131lar i\u00e7in kritik oldu\u011funu g\u00f6steriyor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, bekleyebilecekleriniz \u015funlard\u0131r:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: 16,00-16,50 $ aral\u0131\u011f\u0131 (mevcut seviyelerden %15-16 y\u00fckseli\u015f)<br\/> <strong>Gerek\u00e7e<\/strong>: G\u00fc\u00e7l\u00fc 3. ve 4. \u00e7eyrek performans\u0131 bekleniyor, jenerik pazar geni\u015flemesi devam edecek<\/p> <p><strong>2026 Tahmini<\/strong>: 17,50-18,00 $ (toplam %23-27 y\u00fckseli\u015f)<br\/> <strong>Tetikleyiciler<\/strong>: Yeni \u00fcr\u00fcn lansmanlar\u0131, biyobenzer onaylar\u0131, geli\u015fmekte olan pazar b\u00fcy\u00fcmesi<\/p> <p><strong>2028 Projeksiyonu<\/strong>: 22,00-25,00 $ (%55-76 b\u00fcy\u00fcme potansiyeli)<br\/> <strong>\u0130tici G\u00fc\u00e7ler<\/strong>: Yerle\u015fik biyobenzer portf\u00f6y, geni\u015fletilmi\u015f t\u00fcketici sa\u011fl\u0131\u011f\u0131 b\u00f6l\u00fcm\u00fc<\/p> <p><strong>2030 Vizyonu<\/strong>: 28,00-32,00 $ (%97-125 uzun vadeli de\u011fer art\u0131\u015f\u0131)<br\/> <strong>Temel<\/strong>: K\u00fcresel ila\u00e7 liderli\u011fi, yenilik\u00e7i \u00fcr\u00fcn hatt\u0131 olgunla\u015fmas\u0131<\/p> <p><strong>Sonu\u00e7<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in <strong>G\u00dc\u00c7L\u00dc AL<\/strong>. Makul de\u011ferleme, b\u00fcy\u00fcme potansiyeli ve temett\u00fc geliri kombinasyonu RDY'yi sab\u0131rl\u0131 sermaye i\u00e7in cazip k\u0131l\u0131yor.<\/p> <h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Neler Yanl\u0131\u015f Gidebilir?<\/h2> <p>Her yat\u0131r\u0131m risk ta\u015f\u0131r ve Dr. Reddy's da istisna de\u011fildir:<\/p> <h3>Reg\u00fclasyon Riskleri<\/h3> <ul> <li><strong>FDA incelemesi<\/strong>: New York API tesisindeki son g\u00f6zlemler gecikmelere yol a\u00e7abilir<\/li> <li><strong>Uyum sorunlar\u0131<\/strong>: Mart 2025'te yanl\u0131\u015f etiketlenmi\u015f ila\u00e7 geri \u00e7a\u011fr\u0131s\u0131 kalite kontrol zorluklar\u0131n\u0131 g\u00f6steriyor<\/li> <li><strong>Onay gecikmeleri<\/strong>: Biyobenzer reg\u00fclasyon zamanlamalar\u0131 \u00f6ng\u00f6r\u00fclemezli\u011fini koruyor<\/li> <\/ul> <h3>Piyasa Bask\u0131lar\u0131<\/h3> <ul> <li><strong>Fiyat erozyonu<\/strong>: Jenerik ila\u00e7 fiyatlar\u0131 marjlar\u0131 s\u0131k\u0131\u015ft\u0131rmaya devam ediyor<\/li> <li><strong>D\u00f6viz dalgalanmalar\u0131<\/strong>: %68 uluslararas\u0131 gelir maruziyeti d\u00f6viz riski yarat\u0131yor<\/li> <li><strong>Rekabet<\/strong>: Jenerik ila\u00e7 alan\u0131nda yo\u011fun rekabet<\/li> <\/ul> <h3>Operasyonel Zorluklar<\/h3> <ul> <li><strong>Marj s\u0131k\u0131\u015fmas\u0131<\/strong>: Br\u00fct marj y\u0131ll\u0131k bazda 350 baz puan d\u00fc\u015ft\u00fc<\/li> <li><strong>Kuzey Amerika zay\u0131fl\u0131\u011f\u0131<\/strong>: \u00d6nemli pazar segmentinde %11 gelir d\u00fc\u015f\u00fc\u015f\u00fc<\/li> <li><strong>SG&A b\u00fcy\u00fcmesi<\/strong>: Faaliyet giderleri gelirden daha h\u0131zl\u0131 art\u0131yor<\/li> <\/ul> <h2>\ud83d\udfe2 Pozitif Sinyaller: Yat\u0131r\u0131mc\u0131lar\u0131n Neden \u0130yimser Oldu\u011fu<\/h2> <p>Risklere ra\u011fmen, yat\u0131r\u0131m\u0131 destekleyen birka\u00e7 g\u00fc\u00e7l\u00fc fakt\u00f6r var:<\/p> <h3>G\u00fc\u00e7l\u00fc Temeller<\/h3> <ul> <li><strong>Gelir art\u0131\u015f\u0131<\/strong>: Y\u0131ll\u0131k %11,4 art\u0131\u015f i\u015f momentumunu g\u00f6steriyor<\/li> <li><strong>%17,71 ROE<\/strong>: M\u00fckemmel \u00f6z sermaye getirisi sermayenin verimli kullan\u0131ld\u0131\u011f\u0131n\u0131 g\u00f6steriyor<\/li> <li><strong>Serbest nakit ak\u0131\u015f\u0131<\/strong>: Yakla\u015f\u0131k 14,23 milyar $ finansal esneklik sa\u011fl\u0131yor<\/li> <\/ul> <h3>Analist G\u00fcveni<\/h3> <ul> <li><strong>HSBC y\u00fckseltmesi<\/strong>: \"Tut\"tan \"g\u00fc\u00e7l\u00fc al\"ya 16,90 $ hedef fiyatla<\/li> <li><strong>\u00c7oklu y\u00fckseltmeler<\/strong>: Wall Street Zen ve Zacks Research da iyimser<\/li> <li><strong>Ortak g\u00f6r\u00fc\u015f<\/strong>: Ortalama hedef fiyat 16,95 $ ile \"Orta Al\"<\/li> <\/ul> <h3>Stratejik Konumland\u0131rma<\/h3> <ul> <li><strong>K\u00fcresel ayak izi<\/strong>: Kuzey Amerika, Avrupa, Hindistan, Rusya'da operasyonlar<\/li> <li><strong>\u00dcr\u00fcn hatt\u0131<\/strong>: FDA onay\u0131 bekleyen 73 jenerik dosyas\u0131<\/li> <li><strong>\u0130novasyon odakl\u0131l\u0131k<\/strong>: Ar-Ge gelirlerin %7,3'\u00fcn\u00fc olu\u015fturuyor<\/li> <\/ul> <h2>\ud83d\udcf0 Son Haberlerin Etki Analizi<\/h2> <p>Son alt\u0131 ayda \u00f6nemli geli\u015fmeler ya\u015fand\u0131:<\/p> <h3>Temett\u00fc Art\u0131\u015f\u0131<\/h3> <p>2025 A\u011fustos ba\u015f\u0131nda Dr. Reddy's y\u0131ll\u0131k temett\u00fcs\u00fcn\u00fc \u00f6nceki 0,08 $'dan <strong>hisse ba\u015f\u0131na 0,0915 $<\/strong>'a y\u00fckseltti, bu da <strong>%6,24 getiri<\/strong> anlam\u0131na geliyor. Bu, g\u00fc\u00e7l\u00fc nakit ak\u0131\u015f\u0131 sa\u011fl\u0131\u011f\u0131 ve hissedarlara ba\u011fl\u0131l\u0131\u011f\u0131 g\u00f6steriyor.<\/p> <h3>Hukuki Zafer<\/h3> <p>\u015eirket, Telangana Y\u00fcksek Mahkemesi'nden vergi yeniden de\u011ferlendirme emriyle ilgili ge\u00e7ici durdurma karar\u0131 ald\u0131 ve ge\u00e7ici reg\u00fclasyon istikrar\u0131 sa\u011flad\u0131.<\/p> <h3>Kurumsal Faaliyet<\/h3> <p>Wellington Management Group LLP, portf\u00f6y dengelenmesi nedeniyle hissedeki pay\u0131n\u0131 azaltt\u0131, temel endi\u015fe yok.<\/p> <h2>\ud83c\udfaf Yeni Ba\u015flayanlar \u0130\u00e7in \u0130\u015flem Plan\u0131<\/h2> <p>Kapsaml\u0131 analizlere dayanarak, bug\u00fcn yapman\u0131z gerekenler \u015funlar:<\/p> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-3'\u00fcn\u00fc temsil eden bir pozisyonla ba\u015flay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 kullan\u0131n<\/strong>: Piyasay\u0131 zamanlamaya \u00e7al\u0131\u015fmak yerine sabit miktarlarda ayl\u0131k yat\u0131r\u0131m yap\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Ek al\u0131m f\u0131rsatlar\u0131 i\u00e7in 13,50 $ civar\u0131n\u0131 izleyin<\/li> <li><strong>4 Kas\u0131m'\u0131 izleyin<\/strong>: Kazan\u00e7 sonras\u0131 volatiliteye haz\u0131rl\u0131kl\u0131 olun<\/li> <li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu 3-5 y\u0131ll\u0131k bir yat\u0131r\u0131m hikayesi, h\u0131zl\u0131 bir i\u015flem de\u011fil<\/li> <\/ol> <p><strong>Esprili deneyimli g\u00f6r\u00fc\u015f<\/strong>: \"RDY ticareti, re\u00e7eteli ilac\u0131n etkisini beklemek gibidir - sab\u0131rs\u0131zlar erken satar, sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar tam terap\u00f6tik etkiyi al\u0131r!\"<\/p> <h2>\u2705 Ad\u0131m Ad\u0131m: Dr. Reddy's Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir i\u015flem platformu se\u00e7in<\/td><td>NYSE eri\u015fimi ve makul \u00fccretler sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Genellikle kimlik ve adres belgeleri gerektirir<\/td><\/tr> <tr><td>3<\/td><td>Hesab\u0131n\u0131z\u0131 fonlay\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"RDY\" sembol\u00fcn\u00fc aray\u0131n<\/td><td>\u015eirketin tam ad\u0131 yerine borsa sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Limit emirleri volatilite s\u0131ras\u0131nda a\u015f\u0131r\u0131 \u00f6deme yapmay\u0131 \u00f6nler<\/td><\/tr> <tr><td>6<\/td><td>Emir detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td><td>Komisyon \u00fccretleri ve toplam maliyeti kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Al\u0131m\u0131 ger\u00e7ekle\u015ftirin<\/td><td>Emri onaylay\u0131n ve y\u00fcr\u00fctmeyi izleyin<\/td><\/tr> <tr><td>8<\/td><td>Takip kurun<\/td><td>Pozisyonunuz i\u00e7in fiyat uyar\u0131lar\u0131 olu\u015fturun<\/td><\/tr> <tr><td>9<\/td><td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td><td>K\u00e2r hedefleri ve zarar durdurma seviyelerini belirleyin<\/td><\/tr> <tr><td>10<\/td><td>\u0130\u015flemi belgeleyin<\/td><td>Vergi ve performans takibi i\u00e7in kay\u0131t tutun<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option RDY Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Mant\u0131kl\u0131?<\/h2> <p>Dr. Reddy's Laboratories Limited (RDY) hisselerini d\u00fc\u015f\u00fcnenler i\u00e7in Pocket Option, bu t\u00fcr yat\u0131r\u0131mla m\u00fckemmel uyum sa\u011flayan birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile pozisyonunuzu kademeli olarak olu\u015fturmaya ba\u015flayabilirsiniz<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek belge y\u00fcklemesiyle KYC s\u00fcreci tamamlan\u0131r<\/li> <li><strong>\u00c7ekim Esnekli\u011fi<\/strong>: Yerel banka transferleri dahil y\u00fczlerce y\u00f6ntem<\/li> <li><strong>K\u00fcresel Eri\u015fim<\/strong>: D\u00fcnyan\u0131n neredeyse her yerinden NYSE hisseleri al\u0131m sat\u0131m\u0131<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, Dr. Reddy's ile yat\u0131r\u0131m stratejilerini test etmek i\u00e7in idealdir, daha b\u00fcy\u00fck miktarlara ge\u00e7meden \u00f6nce.<\/p> <h2>\ud83c\udf0d 2025'te Dr. Reddy's: \u0130la\u00e7 Devi<\/h2> <p>Dr. Reddy's Laboratories, ola\u011fan\u00fcst\u00fc bir kapsama alan\u0131yla k\u00fcresel bir ila\u00e7 lideridir:<\/p> <ul> <li><strong>Hasta eri\u015fimi<\/strong>: D\u00fcnya \u00e7ap\u0131nda 800 milyondan fazla hastaya hizmet<\/li> <li><strong>Co\u011frafi varl\u0131k<\/strong>: \u00c7oklu k\u0131talarda 76 \u00fclkede operasyonlar<\/li> <li><strong>\u00dcretim \u00f6l\u00e7e\u011fi<\/strong>: \u0130la\u00e7 ve API \u00fcreten yedi FDA sertifikal\u0131 tesis<\/li> <li><strong>\u00dcr\u00fcn portf\u00f6y\u00fc<\/strong>: 190'dan fazla ila\u00e7 ve 60 aktif farmas\u00f6tik bile\u015fen<\/li> <\/ul> <p>\u015eirket, API tedarik\u00e7isinden g\u00fc\u00e7l\u00fc Ar-Ge yetenekleri ve k\u00fcresel da\u011f\u0131t\u0131m a\u011flar\u0131yla entegre bir ila\u00e7 \u015firketine ba\u015far\u0131l\u0131 bir ge\u00e7i\u015f yapt\u0131.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Dr. Reddy's, \u0130svi\u00e7re merkezli k\u00fcresel bir t\u00fcketici sa\u011fl\u0131\u011f\u0131 i\u015fi ba\u015flatt\u0131 ve edinilen Nikotin Replasman Terapisi portf\u00f6y\u00fcn\u00fc kullanarak geleneksel ila\u00e7lar\u0131n \u00f6tesinde yeni bir b\u00fcy\u00fcme dikeyini olu\u015fturdu.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Mevcut Piyasa Konumu ve Giri\u015f Stratejisi<\/h2>\n<p>31 A\u011fustos 2025 itibar\u0131yla Dr. Reddy&#8217;s Laboratories Limited (RDY), NYSE&#8217;de <strong>14,21 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Bu fiyat seviyesi, hisse senedini ilgin\u00e7 bir konuma yerle\u015ftiriyor &#8211; y\u0131ll\u0131k zirvelerinde de\u011fil ama kesinlikle \u00e7ok ucuz seviyelerde de de\u011fil.<\/p>\n<p><strong>\u00d6nemli Tarih Uyar\u0131s\u0131<\/strong>: Takviminize <strong>4 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin. Dr. Reddy&#8217;s bu tarihte 2. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak ve tarihsel olarak bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden oluyor. Son kazan\u00e7 raporu 25 Temmuz 2025&#8217;te a\u00e7\u0131kland\u0131 ve \u015firket beklentileri a\u015farak hisse ba\u015f\u0131na 0,22 $ ile 0,20 $ tahminlerini %10 oran\u0131nda ge\u00e7ti &#8211; bu genellikle hisseyi hareketlendiren sa\u011flam bir pozitif s\u00fcrprizdir.<\/p>\n<h3>Kazan\u00e7lar\u0131n Etki Analizi<\/h3>\n<p>Son kazan\u00e7 desenlerine bak\u0131ld\u0131\u011f\u0131nda, Dr. Reddy&#8217;s tutarl\u0131 bir performans sergilemi\u015ftir:<\/p>\n<ul>\n<li><strong>Temmuz 2025<\/strong>: 0,22 $ EPS ile tahminleri %10 a\u015ft\u0131<\/li>\n<li><strong>\u00d6nceki \u00e7eyrek<\/strong>: Y\u0131ll\u0131k %11 g\u00fc\u00e7l\u00fc gelir art\u0131\u015f\u0131<\/li>\n<li><strong>Analist g\u00f6r\u00fc\u015f\u00fc<\/strong>: Bir\u00e7ok firma taraf\u0131ndan &#8220;G\u00fc\u00e7l\u00fc Al&#8221; olarak y\u00fckseltildi<\/li>\n<\/ul>\n<p>Bu desen, pozitif kazan\u00e7 s\u00fcrprizlerinin a\u00e7\u0131klamadan sonraki g\u00fcnlerde %3-5 aras\u0131nda anl\u0131k fiyat s\u0131\u00e7ramalar\u0131na yol a\u00e7t\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Seyri ve Trend Analizi<\/h2>\n<p>Dr. Reddy&#8217;s hissesi son alt\u0131 ayda piyasa volatilitesi ve \u015firket \u00f6zel geli\u015fmelerini yans\u0131tan bir ini\u015f \u00e7\u0131k\u0131\u015f ya\u015fad\u0131:<\/p>\n<p><strong>Ocak-Mart 2025<\/strong>: Hisse 13,50-14,00 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc, k\u00fcresel piyasa belirsizli\u011fi i\u00e7inde istikrar g\u00f6sterdi<br \/> <strong>Nisan-Haziran 2025<\/strong>: \u00c7eyrek sonu\u00e7lar\u0131n\u0131n yat\u0131r\u0131mc\u0131lar\u0131 etkilemesiyle 14,50-15,00 $ seviyelerine kademeli y\u00fckseli\u015f<br \/> <strong>Temmuz-A\u011fustos 2025<\/strong>: Kar realizasyonu ve mevcut 14,21 $ seviyelerinde konsolidasyon<\/p>\n<p>Genel trend, <strong>\u0131l\u0131ml\u0131 de\u011fer art\u0131\u015f\u0131<\/strong> ve konsolidasyon d\u00f6nemleri g\u00f6steriyor. Hisse, piyasa d\u00fc\u015f\u00fc\u015flerinde dayan\u0131kl\u0131l\u0131k sergileyerek genellikle daha geni\u015f ila\u00e7 endekslerinin \u00fczerinde performans g\u00f6sterdi.<\/p>\n<p>Teknik g\u00f6stergeler \u015fu anda kar\u0131\u015f\u0131k sinyaller veriyor:<\/p>\n<ul>\n<li><strong>50 G\u00fcnl\u00fck SMA<\/strong>: 14,49 $ (mevcut fiyat biraz alt\u0131nda)<\/li>\n<li><strong>200 G\u00fcnl\u00fck SMA<\/strong>: 14,22 $ (mevcut fiyat bu seviyede)<\/li>\n<li><strong>RSI<\/strong>: 53,81 (n\u00f6tr b\u00f6lge)<\/li>\n<\/ul>\n<p>Bu teknik tablo, hissenin potansiyel bir d\u00f6n\u00fcm noktas\u0131nda oldu\u011funu ve zamanlaman\u0131n yeni yat\u0131r\u0131mc\u0131lar i\u00e7in kritik oldu\u011funu g\u00f6steriyor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, bekleyebilecekleriniz \u015funlard\u0131r:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 16,00-16,50 $ aral\u0131\u011f\u0131 (mevcut seviyelerden %15-16 y\u00fckseli\u015f)<br \/> <strong>Gerek\u00e7e<\/strong>: G\u00fc\u00e7l\u00fc 3. ve 4. \u00e7eyrek performans\u0131 bekleniyor, jenerik pazar geni\u015flemesi devam edecek<\/p>\n<p><strong>2026 Tahmini<\/strong>: 17,50-18,00 $ (toplam %23-27 y\u00fckseli\u015f)<br \/> <strong>Tetikleyiciler<\/strong>: Yeni \u00fcr\u00fcn lansmanlar\u0131, biyobenzer onaylar\u0131, geli\u015fmekte olan pazar b\u00fcy\u00fcmesi<\/p>\n<p><strong>2028 Projeksiyonu<\/strong>: 22,00-25,00 $ (%55-76 b\u00fcy\u00fcme potansiyeli)<br \/> <strong>\u0130tici G\u00fc\u00e7ler<\/strong>: Yerle\u015fik biyobenzer portf\u00f6y, geni\u015fletilmi\u015f t\u00fcketici sa\u011fl\u0131\u011f\u0131 b\u00f6l\u00fcm\u00fc<\/p>\n<p><strong>2030 Vizyonu<\/strong>: 28,00-32,00 $ (%97-125 uzun vadeli de\u011fer art\u0131\u015f\u0131)<br \/> <strong>Temel<\/strong>: K\u00fcresel ila\u00e7 liderli\u011fi, yenilik\u00e7i \u00fcr\u00fcn hatt\u0131 olgunla\u015fmas\u0131<\/p>\n<p><strong>Sonu\u00e7<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in <strong>G\u00dc\u00c7L\u00dc AL<\/strong>. Makul de\u011ferleme, b\u00fcy\u00fcme potansiyeli ve temett\u00fc geliri kombinasyonu RDY&#8217;yi sab\u0131rl\u0131 sermaye i\u00e7in cazip k\u0131l\u0131yor.<\/p>\n<h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Neler Yanl\u0131\u015f Gidebilir?<\/h2>\n<p>Her yat\u0131r\u0131m risk ta\u015f\u0131r ve Dr. Reddy&#8217;s da istisna de\u011fildir:<\/p>\n<h3>Reg\u00fclasyon Riskleri<\/h3>\n<ul>\n<li><strong>FDA incelemesi<\/strong>: New York API tesisindeki son g\u00f6zlemler gecikmelere yol a\u00e7abilir<\/li>\n<li><strong>Uyum sorunlar\u0131<\/strong>: Mart 2025&#8217;te yanl\u0131\u015f etiketlenmi\u015f ila\u00e7 geri \u00e7a\u011fr\u0131s\u0131 kalite kontrol zorluklar\u0131n\u0131 g\u00f6steriyor<\/li>\n<li><strong>Onay gecikmeleri<\/strong>: Biyobenzer reg\u00fclasyon zamanlamalar\u0131 \u00f6ng\u00f6r\u00fclemezli\u011fini koruyor<\/li>\n<\/ul>\n<h3>Piyasa Bask\u0131lar\u0131<\/h3>\n<ul>\n<li><strong>Fiyat erozyonu<\/strong>: Jenerik ila\u00e7 fiyatlar\u0131 marjlar\u0131 s\u0131k\u0131\u015ft\u0131rmaya devam ediyor<\/li>\n<li><strong>D\u00f6viz dalgalanmalar\u0131<\/strong>: %68 uluslararas\u0131 gelir maruziyeti d\u00f6viz riski yarat\u0131yor<\/li>\n<li><strong>Rekabet<\/strong>: Jenerik ila\u00e7 alan\u0131nda yo\u011fun rekabet<\/li>\n<\/ul>\n<h3>Operasyonel Zorluklar<\/h3>\n<ul>\n<li><strong>Marj s\u0131k\u0131\u015fmas\u0131<\/strong>: Br\u00fct marj y\u0131ll\u0131k bazda 350 baz puan d\u00fc\u015ft\u00fc<\/li>\n<li><strong>Kuzey Amerika zay\u0131fl\u0131\u011f\u0131<\/strong>: \u00d6nemli pazar segmentinde %11 gelir d\u00fc\u015f\u00fc\u015f\u00fc<\/li>\n<li><strong>SG&#038;A b\u00fcy\u00fcmesi<\/strong>: Faaliyet giderleri gelirden daha h\u0131zl\u0131 art\u0131yor<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 Pozitif Sinyaller: Yat\u0131r\u0131mc\u0131lar\u0131n Neden \u0130yimser Oldu\u011fu<\/h2>\n<p>Risklere ra\u011fmen, yat\u0131r\u0131m\u0131 destekleyen birka\u00e7 g\u00fc\u00e7l\u00fc fakt\u00f6r var:<\/p>\n<h3>G\u00fc\u00e7l\u00fc Temeller<\/h3>\n<ul>\n<li><strong>Gelir art\u0131\u015f\u0131<\/strong>: Y\u0131ll\u0131k %11,4 art\u0131\u015f i\u015f momentumunu g\u00f6steriyor<\/li>\n<li><strong>%17,71 ROE<\/strong>: M\u00fckemmel \u00f6z sermaye getirisi sermayenin verimli kullan\u0131ld\u0131\u011f\u0131n\u0131 g\u00f6steriyor<\/li>\n<li><strong>Serbest nakit ak\u0131\u015f\u0131<\/strong>: Yakla\u015f\u0131k 14,23 milyar $ finansal esneklik sa\u011fl\u0131yor<\/li>\n<\/ul>\n<h3>Analist G\u00fcveni<\/h3>\n<ul>\n<li><strong>HSBC y\u00fckseltmesi<\/strong>: &#8220;Tut&#8221;tan &#8220;g\u00fc\u00e7l\u00fc al&#8221;ya 16,90 $ hedef fiyatla<\/li>\n<li><strong>\u00c7oklu y\u00fckseltmeler<\/strong>: Wall Street Zen ve Zacks Research da iyimser<\/li>\n<li><strong>Ortak g\u00f6r\u00fc\u015f<\/strong>: Ortalama hedef fiyat 16,95 $ ile &#8220;Orta Al&#8221;<\/li>\n<\/ul>\n<h3>Stratejik Konumland\u0131rma<\/h3>\n<ul>\n<li><strong>K\u00fcresel ayak izi<\/strong>: Kuzey Amerika, Avrupa, Hindistan, Rusya&#8217;da operasyonlar<\/li>\n<li><strong>\u00dcr\u00fcn hatt\u0131<\/strong>: FDA onay\u0131 bekleyen 73 jenerik dosyas\u0131<\/li>\n<li><strong>\u0130novasyon odakl\u0131l\u0131k<\/strong>: Ar-Ge gelirlerin %7,3&#8217;\u00fcn\u00fc olu\u015fturuyor<\/li>\n<\/ul>\n<h2>\ud83d\udcf0 Son Haberlerin Etki Analizi<\/h2>\n<p>Son alt\u0131 ayda \u00f6nemli geli\u015fmeler ya\u015fand\u0131:<\/p>\n<h3>Temett\u00fc Art\u0131\u015f\u0131<\/h3>\n<p>2025 A\u011fustos ba\u015f\u0131nda Dr. Reddy&#8217;s y\u0131ll\u0131k temett\u00fcs\u00fcn\u00fc \u00f6nceki 0,08 $&#8217;dan <strong>hisse ba\u015f\u0131na 0,0915 $<\/strong>&#8216;a y\u00fckseltti, bu da <strong>%6,24 getiri<\/strong> anlam\u0131na geliyor. Bu, g\u00fc\u00e7l\u00fc nakit ak\u0131\u015f\u0131 sa\u011fl\u0131\u011f\u0131 ve hissedarlara ba\u011fl\u0131l\u0131\u011f\u0131 g\u00f6steriyor.<\/p>\n<h3>Hukuki Zafer<\/h3>\n<p>\u015eirket, Telangana Y\u00fcksek Mahkemesi&#8217;nden vergi yeniden de\u011ferlendirme emriyle ilgili ge\u00e7ici durdurma karar\u0131 ald\u0131 ve ge\u00e7ici reg\u00fclasyon istikrar\u0131 sa\u011flad\u0131.<\/p>\n<h3>Kurumsal Faaliyet<\/h3>\n<p>Wellington Management Group LLP, portf\u00f6y dengelenmesi nedeniyle hissedeki pay\u0131n\u0131 azaltt\u0131, temel endi\u015fe yok.<\/p>\n<h2>\ud83c\udfaf Yeni Ba\u015flayanlar \u0130\u00e7in \u0130\u015flem Plan\u0131<\/h2>\n<p>Kapsaml\u0131 analizlere dayanarak, bug\u00fcn yapman\u0131z gerekenler \u015funlar:<\/p>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-3&#8217;\u00fcn\u00fc temsil eden bir pozisyonla ba\u015flay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 kullan\u0131n<\/strong>: Piyasay\u0131 zamanlamaya \u00e7al\u0131\u015fmak yerine sabit miktarlarda ayl\u0131k yat\u0131r\u0131m yap\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Ek al\u0131m f\u0131rsatlar\u0131 i\u00e7in 13,50 $ civar\u0131n\u0131 izleyin<\/li>\n<li><strong>4 Kas\u0131m&#8217;\u0131 izleyin<\/strong>: Kazan\u00e7 sonras\u0131 volatiliteye haz\u0131rl\u0131kl\u0131 olun<\/li>\n<li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu 3-5 y\u0131ll\u0131k bir yat\u0131r\u0131m hikayesi, h\u0131zl\u0131 bir i\u015flem de\u011fil<\/li>\n<\/ol>\n<p><strong>Esprili deneyimli g\u00f6r\u00fc\u015f<\/strong>: &#8220;RDY ticareti, re\u00e7eteli ilac\u0131n etkisini beklemek gibidir &#8211; sab\u0131rs\u0131zlar erken satar, sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar tam terap\u00f6tik etkiyi al\u0131r!&#8221;<\/p>\n<h2>\u2705 Ad\u0131m Ad\u0131m: Dr. Reddy&#8217;s Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir i\u015flem platformu se\u00e7in<\/td>\n<td>NYSE eri\u015fimi ve makul \u00fccretler sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Genellikle kimlik ve adres belgeleri gerektirir<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Hesab\u0131n\u0131z\u0131 fonlay\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;RDY&#8221; sembol\u00fcn\u00fc aray\u0131n<\/td>\n<td>\u015eirketin tam ad\u0131 yerine borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Limit emirleri volatilite s\u0131ras\u0131nda a\u015f\u0131r\u0131 \u00f6deme yapmay\u0131 \u00f6nler<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Emir detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td>\n<td>Komisyon \u00fccretleri ve toplam maliyeti kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Al\u0131m\u0131 ger\u00e7ekle\u015ftirin<\/td>\n<td>Emri onaylay\u0131n ve y\u00fcr\u00fctmeyi izleyin<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Takip kurun<\/td>\n<td>Pozisyonunuz i\u00e7in fiyat uyar\u0131lar\u0131 olu\u015fturun<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td>\n<td>K\u00e2r hedefleri ve zarar durdurma seviyelerini belirleyin<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u0130\u015flemi belgeleyin<\/td>\n<td>Vergi ve performans takibi i\u00e7in kay\u0131t tutun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option RDY Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Mant\u0131kl\u0131?<\/h2>\n<p>Dr. Reddy&#8217;s Laboratories Limited (RDY) hisselerini d\u00fc\u015f\u00fcnenler i\u00e7in Pocket Option, bu t\u00fcr yat\u0131r\u0131mla m\u00fckemmel uyum sa\u011flayan birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile pozisyonunuzu kademeli olarak olu\u015fturmaya ba\u015flayabilirsiniz<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek belge y\u00fcklemesiyle KYC s\u00fcreci tamamlan\u0131r<\/li>\n<li><strong>\u00c7ekim Esnekli\u011fi<\/strong>: Yerel banka transferleri dahil y\u00fczlerce y\u00f6ntem<\/li>\n<li><strong>K\u00fcresel Eri\u015fim<\/strong>: D\u00fcnyan\u0131n neredeyse her yerinden NYSE hisseleri al\u0131m sat\u0131m\u0131<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, Dr. Reddy&#8217;s ile yat\u0131r\u0131m stratejilerini test etmek i\u00e7in idealdir, daha b\u00fcy\u00fck miktarlara ge\u00e7meden \u00f6nce.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Dr. Reddy&#8217;s: \u0130la\u00e7 Devi<\/h2>\n<p>Dr. Reddy&#8217;s Laboratories, ola\u011fan\u00fcst\u00fc bir kapsama alan\u0131yla k\u00fcresel bir ila\u00e7 lideridir:<\/p>\n<ul>\n<li><strong>Hasta eri\u015fimi<\/strong>: D\u00fcnya \u00e7ap\u0131nda 800 milyondan fazla hastaya hizmet<\/li>\n<li><strong>Co\u011frafi varl\u0131k<\/strong>: \u00c7oklu k\u0131talarda 76 \u00fclkede operasyonlar<\/li>\n<li><strong>\u00dcretim \u00f6l\u00e7e\u011fi<\/strong>: \u0130la\u00e7 ve API \u00fcreten yedi FDA sertifikal\u0131 tesis<\/li>\n<li><strong>\u00dcr\u00fcn portf\u00f6y\u00fc<\/strong>: 190&#8217;dan fazla ila\u00e7 ve 60 aktif farmas\u00f6tik bile\u015fen<\/li>\n<\/ul>\n<p>\u015eirket, API tedarik\u00e7isinden g\u00fc\u00e7l\u00fc Ar-Ge yetenekleri ve k\u00fcresel da\u011f\u0131t\u0131m a\u011flar\u0131yla entegre bir ila\u00e7 \u015firketine ba\u015far\u0131l\u0131 bir ge\u00e7i\u015f yapt\u0131.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Dr. Reddy&#8217;s, \u0130svi\u00e7re merkezli k\u00fcresel bir t\u00fcketici sa\u011fl\u0131\u011f\u0131 i\u015fi ba\u015flatt\u0131 ve edinilen Nikotin Replasman Terapisi portf\u00f6y\u00fcn\u00fc kullanarak geleneksel ila\u00e7lar\u0131n \u00f6tesinde yeni bir b\u00fcy\u00fcme dikeyini olu\u015fturdu.<\/p>\n"},"faq":[{"question":"Dr. Reddy's hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir i\u015flem platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"RDY\" sembol\u00fcn\u00fc aray\u0131n, emir t\u00fcr\u00fcn\u00fc se\u00e7in, emir detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin, al\u0131m\u0131 ger\u00e7ekle\u015ftirin, takip kurun, \u00e7\u0131k\u0131\u015f stratejisi planlay\u0131n ve i\u015flemi belgeleyin."},{"question":"Dr. Reddy's hisseleri i\u00e7in riskler nelerdir?","answer":"FDA incelemeleri, uyum sorunlar\u0131, onay gecikmeleri, fiyat erozyonu, d\u00f6viz dalgalanmalar\u0131, yo\u011fun rekabet, marj s\u0131k\u0131\u015fmas\u0131, Kuzey Amerika pazar\u0131ndaki zay\u0131fl\u0131k ve artan i\u015fletme giderleri ba\u015fl\u0131ca risklerdir."},{"question":"Dr. Reddy's hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 16,00-16,50 $, 2026'da 17,50-18,00 $, 2028'de 22,00-25,00 $ ve 2030'da 28,00-32,00 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Pocket Option Dr. Reddy's yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, esnek para \u00e7ekme y\u00f6ntemleri ve k\u00fcresel eri\u015fim gibi avantajlar sunar, b\u00f6ylece yat\u0131r\u0131m stratejilerini test etmek i\u00e7in idealdir."},{"question":"Dr. Reddy's Laboratories'in k\u00fcresel varl\u0131\u011f\u0131 nas\u0131ld\u0131r?","answer":"76 \u00fclkede faaliyet g\u00f6sterir, 800 milyondan fazla hastaya hizmet verir, yedi FDA sertifikal\u0131 \u00fcretim tesisi ve geni\u015f bir \u00fcr\u00fcn portf\u00f6y\u00fcne sahiptir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Dr. Reddy's hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir i\u015flem platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"RDY\" sembol\u00fcn\u00fc aray\u0131n, emir t\u00fcr\u00fcn\u00fc se\u00e7in, emir detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin, al\u0131m\u0131 ger\u00e7ekle\u015ftirin, takip kurun, \u00e7\u0131k\u0131\u015f stratejisi planlay\u0131n ve i\u015flemi belgeleyin."},{"question":"Dr. Reddy's hisseleri i\u00e7in riskler nelerdir?","answer":"FDA incelemeleri, uyum sorunlar\u0131, onay gecikmeleri, fiyat erozyonu, d\u00f6viz dalgalanmalar\u0131, yo\u011fun rekabet, marj s\u0131k\u0131\u015fmas\u0131, Kuzey Amerika pazar\u0131ndaki zay\u0131fl\u0131k ve artan i\u015fletme giderleri ba\u015fl\u0131ca risklerdir."},{"question":"Dr. Reddy's hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 16,00-16,50 $, 2026'da 17,50-18,00 $, 2028'de 22,00-25,00 $ ve 2030'da 28,00-32,00 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Pocket Option Dr. Reddy's yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, esnek para \u00e7ekme y\u00f6ntemleri ve k\u00fcresel eri\u015fim gibi avantajlar sunar, b\u00f6ylece yat\u0131r\u0131m stratejilerini test etmek i\u00e7in idealdir."},{"question":"Dr. Reddy's Laboratories'in k\u00fcresel varl\u0131\u011f\u0131 nas\u0131ld\u0131r?","answer":"76 \u00fclkede faaliyet g\u00f6sterir, 800 milyondan fazla hastaya hizmet verir, yedi FDA sertifikal\u0131 \u00fcretim tesisi ve geni\u015f bir \u00fcr\u00fcn portf\u00f6y\u00fcne sahiptir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Dr. Reddy&#039;s Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dr. Reddy&#039;s Laboratories Limited (RDY) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr. Reddy&#039;s Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dr. Reddy&#039;s Laboratories Limited (RDY) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-31T08:22:19+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Dr. Reddy&#8217;s Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Dr. Reddy&#8217;s Laboratories Limited (RDY) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-31T08:22:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/\"},\"wordCount\":25,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/\",\"name\":\"Dr. Reddy's Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dr. Reddy's Laboratories Limited (RDY) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"datePublished\":\"2025-08-31T08:22:19+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr. Reddy&#8217;s Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Dr. Reddy&#8217;s Laboratories Limited (RDY) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Dr. Reddy's Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dr. Reddy's Laboratories Limited (RDY) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/","og_locale":"tr_TR","og_type":"article","og_title":"Dr. Reddy's Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dr. Reddy's Laboratories Limited (RDY) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-31T08:22:19+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Dr. Reddy&#8217;s Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Dr. Reddy&#8217;s Laboratories Limited (RDY) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-31T08:22:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"},"wordCount":25,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/","name":"Dr. Reddy's Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dr. Reddy's Laboratories Limited (RDY) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","datePublished":"2025-08-31T08:22:19+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Dr. Reddy&#8217;s Laboratories Limited (RDY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Dr. Reddy&#8217;s Laboratories Limited (RDY) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":362475,"slug":"how-to-buy-dr-reddys-laboratories-limited","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Dr. Reddy's Laboratories Limited (RDY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Dr. Reddy's Laboratories Limited (RDY)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"},"pt_AA":{"locale":"pt_AA","id":362467,"slug":"how-to-buy-dr-reddys-laboratories-limited","post_title":"Como comprar a\u00e7\u00f5es da Dr. Reddy's Laboratories Limited (RDY) - Investimento em a\u00e7\u00f5es da Dr. Reddy's Laboratories Limited (RDY)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-dr-reddys-laboratories-limited\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/362476","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=362476"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/362476\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334045"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=362476"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=362476"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=362476"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}